Suppr超能文献

一种可生物降解、持续释放的醋酸泼尼松龙微孔膜药物传递系统可有效延长大鼠角膜移植模型中同种异体角膜移植物的存活时间。

A biodegradable, sustained-released, prednisolone acetate microfilm drug delivery system effectively prolongs corneal allograft survival in the rat keratoplasty model.

机构信息

Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore.

出版信息

PLoS One. 2013 Aug 5;8(8):e70419. doi: 10.1371/journal.pone.0070419. Print 2013.

Abstract

Frequent and long-term use of topical corticosteroids after corneal transplantation is necessary to prevent graft rejection. However, it relies heavily on patient compliance, and sustained therapeutic drug levels are often not achieved with administration of topical eye drops. A biodegradable drug delivery system with a controlled and sustained drug release may circumvent these limitations. In this study, we investigated the efficacy of a prednisolone acetate (PA)-loaded poly (d,l-lactide-co-ε-caprolactone) (PLC) microfilm drug delivery system on promoting the survival of allogeneic grafts after penetrating keratoplasty (PK) using a rat model. The drug release profiles of the microfilms were characterized (group 1). Subsequently, forty-eight PK were performed in four experimental groups: syngeneic control grafts (group 2), allogeneic control grafts (group 3), allogeneic grafts with subconjunctivally-implanted PA microfilm (group 4), and allogeneic grafts with PA eye drops (group 5; n = 12 in each). PA-loaded microfilm achieved a sustained and steady release at a rate of 0.006-0.009 mg/day, with a consistent aqueous drug concentration of 207-209 ng/ml. The mean survival days was >28 days in group 2, 9.9±0.8 days in group 3, 26.8±2.7 days in group 4, and 26.4±3.4 days in group 5 (P = 0.023 and P = 0.027 compared with group 3). Statistically significant decrease in CD4+, CD163+, CD 25+, and CD54+ cell infiltration was observed in group 4 and group 5 compared with group 3 (P<0.001). There was no significant difference in the mean survival and immunohistochemical analysis between group 4 and group 5. These results showed that sustained PA-loaded microfilm effectively prolongs corneal allograft survival. It is as effective as conventional PA eye drops, providing a promising clinically applicable alternative for patients undergoing corneal transplantation.

摘要

频繁且长期使用局部皮质类固醇(topical corticosteroids)是预防移植物排斥反应所必需的。然而,这种方法严重依赖于患者的依从性,并且通过局部滴眼剂给药往往无法达到持续的治疗药物水平。具有控制和持续药物释放的生物可降解药物递送系统可能会规避这些限制。在这项研究中,我们使用大鼠模型研究了负载醋酸泼尼松龙(prednisolone acetate,PA)的聚(丙交酯-共-ε-己内酯)(poly (d,l-lactide-co-ε-caprolactone),PLC)微孔膜药物递送系统在穿透性角膜移植(penetrating keratoplasty,PK)后促进同种异体移植物存活的效果。我们对微膜的药物释放曲线进行了特征描述(第 1 组)。随后,在四个实验组中进行了 48 例 PK:同基因对照移植物(第 2 组)、同种异体对照移植物(第 3 组)、同种异体移植物联合结膜下植入 PA 微孔膜(第 4 组)和同种异体移植物联合 PA 滴眼剂(第 5 组;每组 n=12)。负载 PA 的微孔膜以 0.006-0.009 mg/天的速率实现了持续稳定的释放,水相药物浓度保持在 207-209 ng/ml 左右。第 2 组的平均存活天数>28 天,第 3 组为 9.9±0.8 天,第 4 组为 26.8±2.7 天,第 5 组为 26.4±3.4 天(与第 3 组相比,P=0.023 和 P=0.027)。与第 3 组相比,第 4 组和第 5 组观察到 CD4+、CD163+、CD25+和 CD54+细胞浸润明显减少(P<0.001)。第 4 组和第 5 组之间的平均存活时间和免疫组织化学分析无显著差异。这些结果表明,持续负载 PA 的微膜可有效延长角膜同种异体移植物的存活时间。它与传统的 PA 滴眼剂一样有效,为接受角膜移植的患者提供了一种有前途的临床应用替代方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f251/3734265/80b70b5250b6/pone.0070419.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验